Publications

Export 21 results:
Author [ Title(Desc)] Type Year
Filters: Author is Sylvia Villeneuve  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Meyer P-F, McSweeney M, Gonneaud J, Villeneuve S.  2019.  AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention.. Prog Mol Biol Transl Sci. 165:63-106.
Binette APichet, Vachon-Presseau E, Morris J, Bateman R, Benzinger T, D Collins L, Poirier J, Breitner JCS, Villeneuve S.  2020.  Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease.. Biol Psychiatry.
Villeneuve S, Wirth M, La Joie R.  2015.  Are AD-Typical Regions the Convergence Point of Multiple Pathologies? Front Aging Neurosci. 7:42.
Gonneaud J, Bedetti C, Binette APichet, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S.  2020.  Association of education with Aβ burden in preclinical familial and sporadic Alzheimer disease.. Neurology. 95(11):e1554-e1564.
Han JWon, Maillard P, Harvey D, Fletcher E, Martinez O, Johnson DK, Olichney JM, Farias ST, Villeneuve S, Jagust W et al..  2020.  Association of vascular brain injury, neurodegeneration, amyloid and cognitive trajectory.. Neurology.
B
Vogel JW, Vachon-Presseau E, Binette APichet, Tam A, Orban P, La Joie R, Savard M, Picard C, Poirier J, Bellec P et al..  2018.  Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.. Brain. 141(6):1871-1883.
C
Villeneuve S.  2016.  Cause of Suspected Non-Alzheimer Disease Pathophysiology: If Not Tau Pathology, Then What? JAMA Neurol. 73(10):1177-1179.
E
Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SKate, Vogel JW, Marks SM et al..  2015.  Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.. Brain. 138(Pt 7):2020-33.
I
Villeneuve S, Jagust WJ.  2015.  Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment.. J Prev Alzheimers Dis. 2(1):64-70.
Ossenkoppele R, Leuzy A, Cho H, Sudre CH, Strandberg O, Smith R, Palmqvist S, Mattsson-Carlgren N, Olsson T, Jögi J et al..  2020.  The impact of demographic, clinical, genetic, and imaging variables on tau PET status.. Eur J Nucl Med Mol Imaging.
L
Villeneuve S.  2019.  Lifespan Cognitive Reserve-A Secret to Coping With Neurodegenerative Pathology.. JAMA Neurol. 76(10):1145-1146.
M
Binette APichet, Gonneaud J, Vogel JW, La Joie R, Rosa-Neto P, D Collins L, Poirier J, Breitner JCS, Villeneuve S, Vachon-Presseau E.  2020.  Morphometric network differences in ageing versus Alzheimer's disease dementia.. Brain. 143(2):635-649.
Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M.  2017.  Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.. Neurology. 88(6):569-576.
P
Villeneuve S, Vogel JW, Gonneaud J, Binette APichet, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TLS et al..  2018.  Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.. JAMA Neurol.
R
Seo SWon, Ayakta N, Grinberg LT, Villeneuve S, Lehmann M, Reed B, DeCarli C, Miller BL, Rosen HJ, Boxer AL et al..  2017.  Regional correlations between [(11)C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort.. Neuroimage Clin. 13:130-137.
Marchant NL, Lovland LR, Jones R, Binette APichet, Gonneaud J, Arenaza-Urquijo EM, Chételat G, Villeneuve S.  2020.  Repetitive negative thinking is associated with amyloid, tau, and cognitive decline.. Alzheimers Dement. 16(7):1054-1064.
S
Verfaillie SCJ, Binette APichet, Vachon-Presseau E, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JCS et al..  2017.  Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer’s Disease.
Verfaillie SCJ, Binette APichet, Vachon-Presseau E, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JCS et al..  2018.  Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease.. Biol Psychiatry Cogn Neurosci Neuroimaging. 3(5):463-472.
V
Köbe T, Binette APichet, Vogel JW, Meyer P-F, Breitner JCS, Poirier J, Villeneuve S.  2021.  Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes.. Neuroimage. 231:117832.
W
Mander BA, Zhu AH, Lindquist JR, Villeneuve S, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust WJ, Walker MP.  2017.  White Matter Structure in Older Adults Moderates the Benefit of Sleep Spindles on Motor Memory Consolidation.. J Neurosci. 37(48):11675-11687.
Β
Fletcher E, Villeneuve S, Maillard P, Harvey D, Reed B, Jagust W, DeCarli C.  2016.  β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals.. Neurobiol Aging. 40:173-80.